Radiculopathy  >>  ralfinamide (NW-1029)  >>  Phase 3
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ralfinamide (NW-1029) / Newron
NCT01019824 / 2008-006176-30: Efficacy and Safety of Ralfinamide in Patients With Chronic Neuropathic Low Back Pain

Completed
3
411
Europe
Ralfinamide
Newron Pharmaceuticals SPA, Parexel, CliniRx
Pain
05/10
08/11

Download Options